Neurocrine Biosciences (NBIX) Gross Margin (2017 - 2026)
Neurocrine Biosciences (NBIX) posted Gross Margin of 97.58% for Q2 2026, down 0.92 percentage points from 98.50% a year earlier and down 0.72 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Gross Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Neurocrine Biosciences was 97.97%, down 0.57 percentage points year-over-year; for FY2025, it was 98.18%, down 0.38 percentage points from FY2024.
- Annual Gross Margin shows a five-year change of -0.86 percentage points (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Gross Margin was 98.56% in FY2024 (+0.66 pp), 97.90% in FY2023 (-0.55 pp), 98.44% in FY2022 (-0.30 pp) and 98.74% in FY2021 (-0.30 pp).
- The Q2 2026 figure stands as the lowest quarterly Gross Margin since Q2 2023.
- On a year-over-year basis, Gross Margin has declined in each of the last four quarters, with an average year-over-year change of -0.14 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2024, with a gain of 0.98 percentage points; the weakest was Q2 2023, with a drop of 1.27 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 98.31% (Q1 2026), 97.82% (Q4 2025) and 98.24% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 97.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 97.58% |
| Mar 31, 2026 | 98.31% |
| Dec 31, 2025 | 97.82% |
| Sep 30, 2025 | 98.24% |
| Jun 30, 2025 | 98.50% |
| Mar 31, 2025 | 98.39% |
| Dec 31, 2024 | 98.52% |
| Sep 30, 2024 | 98.71% |
| Jun 30, 2024 | 98.44% |
| Mar 31, 2024 | 98.54% |
| Dec 31, 2023 | 98.35% |
| Sep 30, 2023 | 97.75% |
| Jun 30, 2023 | 97.46% |
| Mar 31, 2023 | 97.98% |
| Dec 31, 2022 | 98.13% |
| Sep 30, 2022 | 98.43% |
| Jun 30, 2022 | 98.73% |
| Mar 31, 2022 | 98.52% |
| Dec 31, 2021 | 98.69% |
| Sep 30, 2021 | 98.58% |
API Access
Neurocrine Biosciences Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();